High Galectin-1 expression has been associated with poor prognosis in various cancers, including ovarian cancer [12], glioblastoma [55], renal cell cancer [56], head and neck squamous cell carcinoma [57], and non–small-cell lung cancer [9]. Here, LGALS1 is linked to renal cell adenocarcinoma.